Clearside Biomedical Inc. (CLSD)
0.93
0.02 (2.47%)
At close: Apr 02, 2025, 3:59 PM
0.95
1.68%
After-hours: Apr 02, 2025, 07:53 PM EDT
Clearside Biomedical Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
| Cash & Equivalents | 20.02M | 28.92M | 48.26M | 30.44M | 17.29M | 22.59M | 8.04M | 9.22M | 34.82M | 20.28M | 8.27M | 1.91M | 856K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 32.84M | 28.42M | 48.81M | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 30K | 160K | 260K | 360K | 360K | 360K | 360K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 30K | 30K | 1.14M | n/a | n/a | n/a | 26K | -885K | -94K | 417K | 1.77M | 22K | -50K |
| Receivables | 507K | 170K | n/a | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | 921K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 747K | 311K | 439K | 779K | 109K | 1.49M | 17K | 116K | 290K | 40K | 7K | 45K | n/a |
| Total Current Assets | 21.27M | 30.12M | 48.26M | 42.14M | 18.12M | 25.22M | 42.94M | 37.64M | 83.63M | 20.48M | 8.32M | 2.02M | 883K |
| Property-Plant & Equipment | 3.82M | 3.87M | 1.87M | 607K | 944K | 1.2M | 790K | 885K | 94K | 156K | 205K | 98K | 50K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.85M | 3.9M | 3.04M | 767K | 1.2M | 1.56M | 1.18M | 360K | 360K | 573K | 1.98M | 120K | 50K |
| Total Assets | 25.13M | 34.02M | 51.3M | 42.9M | 19.32M | 26.78M | 44.12M | 40.49M | 84.81M | 21.05M | 10.3M | 2.14M | 948K |
| Account Payables | n/a | 2.21M | 1.05M | 941K | 2M | 1.28M | 6.87M | 5.38M | 2.59M | 1.47M | 1.26M | 248K | n/a |
| Deferred Revenue | n/a | 75K | 205K | n/a | 5M | 5M | n/a | 140K | 160K | n/a | n/a | n/a | n/a |
| Short-Term Debt | 375K | n/a | 349K | 387K | 1.36M | 1.69M | 556K | 3.2M | n/a | 1.73M | n/a | n/a | n/a |
| Other Current Liabilities | 4.42M | 1.86M | 1.99M | 1.47M | 759K | 1.92M | 1.86M | 219K | 23K | 9K | 835K | 113K | 293K |
| Total Current Liabilities | 4.79M | 6.81M | 5.78M | 4.64M | 9.94M | 10.9M | 10.48M | 13.52M | 5.41M | 5.2M | 2.42M | 683K | 531K |
| Long-Term Debt | 328K | 41.99M | n/a | n/a | n/a | 3.82M | 9.42M | 4.81M | 7.59M | 4.24M | n/a | 268K | 150K |
| Other Long-Term Liabilities | 58.86M | 480K | 33.98M | n/a | n/a | n/a | 605K | 610K | n/a | 258K | 26.89M | 11.92M | n/a |
| Total Long-Term Liabilities | 59.19M | 43.12M | 33.98M | 288K | 616K | 4.72M | 10.02M | 8.01M | 7.59M | 52.52M | 27.09M | 12.19M | 150K |
| Total Liabilities | 63.98M | 49.93M | 40.7M | 4.93M | 10.56M | 15.62M | 20.5M | 19.08M | 13.15M | 57.71M | 29.51M | 12.88M | 709K |
| Total Debt | 703K | 43M | 1.28M | 675K | 1.98M | 6.41M | 9.97M | 8.01M | 7.59M | 5.98M | n/a | 268K | n/a |
| Common Stock | 77K | 63K | 61K | 60K | 52K | 44K | 32K | 25K | 25K | 3K | 4K | 3K | 2K |
| Retained Earnings | -355.27M | -320.92M | -288.44M | -255.49M | -255.87M | -237.66M | -206.89M | -124.22M | -65.25M | -39.36M | -21.72M | -11.54M | -4.28M |
| Comprehensive Income | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | -8K | -13K | -103K | -55K | -22K | n/a |
| Shareholders Equity | -38.85M | -15.91M | 10.61M | 37.98M | 8.76M | 11.16M | 23.62M | 21.41M | 71.66M | -36.66M | -19.21M | -10.74M | 239K |
| Total Investments | n/a | n/a | 30K | 160K | 260K | 360K | 32.84M | 28.42M | 48.81M | n/a | n/a | n/a | n/a |